Article

Turmeric May Fight Diabetes and Obesity

Columbia Medical School researchers at the Naomi Berrie Diabetes Center have found that the common Asian cooking spice turmeric may help prevent diabetes.

Columbia Medical School researchers at the Naomi Berrie Diabetes Center have found that the common Asian cooking spice turmeric may help prevent diabetes.

Drew Tortoriello, MD, research scientist at the center, along with pediatric resident Stuart Weisberg, MD, PhD, and Rudolph Leibel, MD, co-director of the Naomi Berrie Diabetes Center, together studied the effect of this spice on diabetic mice. Turmeric has long been known to be an anti-inflammatory and anti-oxidant agent used to reduce inflammation, relieve pain, and heal wounds. It is also believed that inflammation plays a role in the onset of Type 2 diabetes and obesity.

To study a possible beneficial effect, researchers gave high doses of turmeric to two types of mice: “high-fat-diet-fed male mice and leptin-deficient obese female mice, with lean wild-type mice that were fed low-fat diets used as controls.”

Findings suggested that turmeric’s active ingredient curcumin may be able to reverse the metabolic and inflammatory problems related with obesity. It also appeared to improve blood-sugar control in the mice with type 2 diabetes.

The research is still in the early stages; whether increasing dietary curcumin intake among obese and diabetic patients would be beneficial has yet to be determined.

“Although the daily intake of curcumin one might have to consume as a primary diabetes treatment is likely impractical, it is entirely possible that lower dosages of curcumin could nicely complement our traditional therapies as a natural and safe treatment,” said Dr. Tortoriello in a recent press release.

Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
Diabetes Dialogue: Diabetes Tech Updates from November 2024 | Image Credit: HCPLive
Viet Le, DMSc, PA-C | Credit: APAC
© 2024 MJH Life Sciences

All rights reserved.